Becker JC - Search Results

1

Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progression.

Terheyden P, Schrama D, Pedersen LØ, Andersen MH, Kämpgen E, thor Straten P, Becker JC. Terheyden P, et al. Among authors: becker jc. Scand J Immunol. 2003 Nov;58(5):566-71. doi: 10.1046/j.1365-3083.2003.01324.x. Scand J Immunol. 2003. PMID: 14629628 Free article.

2

CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.

Terheyden P, Straten P, Bröcker EB, Kämpgen E, Becker JC. Terheyden P, et al. Among authors: becker jc. J Immunol. 2000 Jun 15;164(12):6633-9. doi: 10.4049/jimmunol.164.12.6633. J Immunol. 2000. PMID: 10843723

3

Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node.

Becker JC, Vetter CS, Schrama D, Bröcker EB, thor Straten P. Becker JC, et al. Eur J Immunol. 2000 Dec;30(12):3699-706. doi: 10.1002/1521-4141(200012)30:12<3699::AID-IMMU3699>3.0.CO;2-2. Eur J Immunol. 2000. PMID: 11169413 Free article.

4

Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients.

Schrama D, Andersen MH, Terheyden P, Schrøder L, Pedersen LO, thor Straten P, Becker JC. Schrama D, et al. Among authors: becker jc. Cancer Res. 2001 Jan 15;61(2):493-6. Cancer Res. 2001. PMID: 11212239

5

CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.

Voigt H, Schrama D, Eggert AO, Vetter CS, Müller-Blech K, Reichardt HM, Andersen MH, Becker JC, Lühder F. Voigt H, et al. Among authors: becker jc. Clin Exp Immunol. 2006 Jan;143(1):93-102. doi: 10.1111/j.1365-2249.2005.02972.x. Clin Exp Immunol. 2006. PMID: 16367939 Free PMC article.

6

Molecular basis of T-cell dysfunction in melanoma.

Becker JC, Terheyden P, Bröcker EB. Becker JC, et al. Melanoma Res. 1997 Aug;7 Suppl 2:S51-7. Melanoma Res. 1997. PMID: 9578417 Review.

7

[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature].

Terheyden P, Kämpgen E, Rünger TM, Bröcker EB, Becker JC. Terheyden P, et al. Among authors: becker jc. Hautarzt. 1998 Oct;49(10):770-3. doi: 10.1007/s001050050823. Hautarzt. 1998. PMID: 9857252 Review. German.

8

Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis.

Terheyden P, Siedel C, Merkel A, Kämpgen E, Bröcker EB, Becker JC. Terheyden P, et al. Among authors: becker jc. J Invest Dermatol. 1999 Jun;112(6):899-902. doi: 10.1046/j.1523-1747.1999.00607.x. J Invest Dermatol. 1999. PMID: 10383736 Free article.

9

Function and dysfunction of CD4(+) T cells in the immune response to melanoma.

Fischer WH, thor Straten P, Terheyden P, Becker JC. Fischer WH, et al. Among authors: becker jc. Cancer Immunol Immunother. 1999 Oct;48(7):363-70. doi: 10.1007/s002620050587. Cancer Immunol Immunother. 1999. PMID: 10501848 Free PMC article. Review.

10

In situ T cells in melanoma.

thor Straten P, Becker JC, Guldberg P, Zeuthen J. thor Straten P, et al. Among authors: becker jc. Cancer Immunol Immunother. 1999 Oct;48(7):386-95. doi: 10.1007/s002620050591. Cancer Immunol Immunother. 1999. PMID: 10501852 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters